An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies

Over the last three years, after the outbreak of the COVID-19 pandemic, an unprecedented number of novel diagnostic tests have been developed. Assays to evaluate the immune response to SARS-CoV-2 have been widely considered as part of the control strategy. The lateral flow immunoassay (LFIA), to det...

Descrición completa

Detalles Bibliográficos
Main Authors: Lucia Spicuzza, Davide Campagna, Chiara Di Maria, Enrico Sciacca, Salvatore Mancuso, Carlo Vancheri, Gianluca Sambataro
Formato: Artigo
Idioma:English
Publicado: AIMS Press 2023-04-01
Series:AIMS Microbiology
Subjects:
Acceso en liña:https://www.aimspress.com/article/doi/10.3934/microbiol.2023020?viewType=HTML